| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 287,289 | 306,220 | 484,106 | 375,793 | | Cost of Revenue | 304,227 | 50,837 | 152,069 | 453,375 | | | Gross Profit | (16,938) | 255,383 | 332,037 | (77,582) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (161,416) | 103,668 | 114,847 | (252,581) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 62,629 | 57,570 | 55,714 | 55,881 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 81,849 | 94,145 | 161,476 | 119,118 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,307 | 2,647 | (1,485) | (3,527) | | Earnings Before Interest And Taxes | 84,156 | 96,792 | 159,991 | 115,591 | | Interest Expense | 10,017 | 9,788 | 9,781 | 10,282 | | Income Before Tax | 74,139 | 87,004 | 150,210 | 105,309 | | Income Tax Expense | 27,018 | 32,003 | 54,628 | 40,024 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 47,121 | 55,001 | 95,582 | 65,285 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 47,121 | 55,001 | 95,582 | 65,285 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $47,121 | $55,001 | $95,582 | $65,285 |
|
0.31% Nasdaq 
0.05%
Income Statement
